Marcel Kool

84.4k total citations · 6 hit papers
215 papers, 14.4k citations indexed

About

Marcel Kool is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Marcel Kool has authored 215 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Molecular Biology, 83 papers in Genetics and 34 papers in Cancer Research. Recurrent topics in Marcel Kool's work include Glioma Diagnosis and Treatment (83 papers), Chromatin Remodeling and Cancer (56 papers) and Hedgehog Signaling Pathway Studies (42 papers). Marcel Kool is often cited by papers focused on Glioma Diagnosis and Treatment (83 papers), Chromatin Remodeling and Cancer (56 papers) and Hedgehog Signaling Pathway Studies (42 papers). Marcel Kool collaborates with scholars based in Germany, Netherlands and United States. Marcel Kool's co-authors include Piet Borst, Raymond Evers, Jan Wijnholds, Stefan M. Pfister, Frank Baas, Marcel de Haas, Andrey Korshunov, Rik J. Scheper, George L. Scheffer and Just M. Vlak and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Marcel Kool

208 papers receiving 14.2k citations

Hit Papers

A Family of Drug Transporters: the Multidrug Resistance-A... 1997 2026 2006 2016 2000 2011 1997 1998 1999 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins
    2000 1.4k citations Piet Borst, Raymond Evers et al. JNCI Journal of the National Cancer Institute profile →
  2. Molecular subgroups of medulloblastoma: the current consensus
    2011 1.2k citations Michael D. Taylor, Steven C. Clifford et al. Acta Neuropathologica profile →
  3. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
    1997 746 citations Marcel Kool, Marcel de Haas et al. PubMed profile →
  4. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.
    1998 529 citations Raymond Evers, Marcel Kool et al. profile →
  5. The multidrug resistance protein family
    1999 525 citations Piet Borst, Raymond Evers et al. profile →
  6. MRP3, an organic anion transporter able to transport anti-cancer drugs
    1999 521 citations Marcel Kool, Marcel van der Linden et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Kool Germany 51 8.2k 5.5k 3.6k 2.1k 1.7k 215 14.4k
Marina Konopleva United States 94 15.8k 1.9× 7.9k 1.4× 5.9k 1.6× 769 0.4× 3.4k 2.0× 917 30.5k
Zeev Estrov United States 82 11.7k 1.4× 4.8k 0.9× 10.5k 2.9× 460 0.2× 2.0k 1.1× 669 26.3k
Antonio Tito Fojo United States 48 6.9k 0.8× 8.4k 1.5× 580 0.2× 1.3k 0.6× 1.5k 0.8× 137 13.6k
Ugo Testa Italy 68 8.7k 1.1× 3.0k 0.5× 2.3k 0.6× 473 0.2× 2.7k 1.5× 423 16.9k
Maher Albitar United States 65 7.5k 0.9× 4.5k 0.8× 8.2k 2.2× 351 0.2× 1.5k 0.9× 342 20.0k
Hubert Serve Germany 59 8.5k 1.0× 3.1k 0.6× 2.6k 0.7× 404 0.2× 2.9k 1.7× 299 15.5k
Igor B. Roninson United States 67 11.1k 1.4× 10.6k 1.9× 575 0.2× 1.8k 0.8× 1.4k 0.8× 158 18.1k
Tomoki Naoe Japan 56 8.1k 1.0× 2.9k 0.5× 2.7k 0.8× 282 0.1× 2.9k 1.7× 352 15.9k
Steven M. Kornblau United States 69 8.3k 1.0× 3.4k 0.6× 2.6k 0.7× 386 0.2× 2.1k 1.2× 406 15.4k
Guido Marcucci United States 77 14.3k 1.8× 3.1k 0.6× 3.2k 0.9× 436 0.2× 6.1k 3.5× 489 22.5k

Countries citing papers authored by Marcel Kool

Since Specialization
Citations

This map shows the geographic impact of Marcel Kool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Kool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Kool more than expected).

Fields of papers citing papers by Marcel Kool

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Kool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Kool. The network helps show where Marcel Kool may publish in the future.

Co-authorship network of co-authors of Marcel Kool

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Kool. A scholar is included among the top collaborators of Marcel Kool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Kool. Marcel Kool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Duy, Sara Najafi, Norman Mack, et al.. (2024). Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours. British Journal of Cancer. 131(4). 763–777. 1 indexed citations
2.
Madlener, Sibylle, Christine Haberler, Walter Berger, et al.. (2024). EPEN-12. EZHIP IMPACTS CELLULAR DIFFERENTIATION IN POSTERIOR FOSSA GROUP A EPENDYMOMA. Neuro-Oncology. 26(Supplement_4). 0–0.
3.
Williams, Justin, Femke Ringnalda, Natalia Moreno, et al.. (2023). Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities. Oncogene. 42(20). 1661–1671. 15 indexed citations
4.
Ramaswamy, Vijay, Marcel Kool, Brigitta Stockinger, et al.. (2020). The AHR pathway represses TGFβ-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma. Scientific Reports. 10(1). 148–148. 20 indexed citations
5.
Tao, Ran, Najiba Murad, Zhenhua Xu, et al.. (2019). MYC Drives Group 3 Medulloblastoma through Transformation of Sox2+ Astrocyte Progenitor Cells. Cancer Research. 79(8). 1967–1980. 29 indexed citations
6.
Dyberg, Cecilia, Thale Kristin Olsen, Bertha Brodin, et al.. (2019). Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth. Cancers. 12(1). 73–73. 10 indexed citations
7.
8.
Akgül, Seçkin, Yinghua Li, Siyuan Zheng, et al.. (2018). Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma. Cell Reports. 24(2). 463–478.e5. 20 indexed citations
9.
Witt, Hendrik, Dorothee Gramatzki, Bettina Hentschel, et al.. (2018). DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment. Neuro-Oncology. 20(12). 1616–1624. 59 indexed citations
10.
Erdreich‐Epstein, Anat, Nathan Robison, Xiuhai Ren, et al.. (2013). PID1 ( NYGGF4 ), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and Gliomas. Clinical Cancer Research. 20(4). 827–836. 26 indexed citations
11.
Warmuth‐Metz, Monika, André O. von Bueren, Marcel Kool, et al.. (2012). Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Acta Neuropathologica. 123(4). 601–614. 55 indexed citations
12.
Smits, Michiel, Sjoerd van Rijn, Esther Hulleman, et al.. (2012). EZH2-Regulated DAB2IP Is a Medulloblastoma Tumor Suppressor and a Positive Marker for Survival. Clinical Cancer Research. 18(15). 4048–4058. 58 indexed citations
13.
Elshout, Gijs, Marcel Kool, Johannes C. van der Wouden, et al.. (2012). Antibiotic Prescription in Febrile Children: A Cohort Study during Out-of-Hours Primary Care. The Journal of the American Board of Family Medicine. 25(6). 810–818. 31 indexed citations
14.
Schaaf, Gerben, Mohamed Hamdi, Danny A. Zwijnenburg, et al.. (2010). Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene. Cancer Research. 70(2). 762–771. 55 indexed citations
15.
Bunt, Jens, Nancy E. Hasselt, Danny A. Zwijnenburg, et al.. (2010). Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines. Molecular Cancer Research. 8(10). 1344–1357. 36 indexed citations
16.
Hasselt, Nancy E., Dirk Troost, Huib N. Caron, et al.. (2008). Molecular Risk Stratification of Medulloblastoma Patients Based on Immunohistochemical Analysis of MYC, LDHB, and CCNB1 Expression. Clinical Cancer Research. 14(13). 4154–4160. 41 indexed citations
17.
18.
Borst, Piet, Raymond Evers, Marcel Kool, & Jan Wijnholds. (2000). A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins. JNCI Journal of the National Cancer Institute. 92(16). 1295–1302. 1386 indexed citations breakdown →
19.
Kool, Marcel, Marcel van der Linden, Marcel de Haas, et al.. (1999). MRP3, an organic anion transporter able to transport anti-cancer drugs. Proceedings of the National Academy of Sciences. 96(12). 6914–6919. 521 indexed citations breakdown →
20.
Kool, Marcel, Mariëtta L. van der Linden, Marcel de Haas, Frank Baas, & Piet Borst. (1999). Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells.. PubMed. 59(1). 175–82. 298 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Konopleva Breakdown of academic impact, for papers by Zeev Estrov Breakdown of academic impact, for papers by Antonio Tito Fojo Breakdown of academic impact, for papers by Ugo Testa Breakdown of academic impact, for papers by Maher Albitar Breakdown of academic impact, for papers by Hubert Serve Breakdown of academic impact, for papers by Igor B. Roninson Breakdown of academic impact, for papers by Tomoki Naoe Breakdown of academic impact, for papers by Steven M. Kornblau Breakdown of academic impact, for papers by Guido Marcucci
Rankless by CCL
2026